Longhorn Auto Co Ltd
SZSE:301488
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Longhorn Auto Co Ltd
SZSE:301488
|
CN |
|
N
|
Nanjing Well Pharmaceutical Co Ltd
SSE:603351
|
CN |
|
Moury Construct SA
LSE:0NZS
|
BE |
Income Statement
Earnings Waterfall
Longhorn Auto Co Ltd
Income Statement
Longhorn Auto Co Ltd
| Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Interest Expense |
2
|
2
|
3
|
0
|
8
|
5
|
0
|
0
|
|
| Revenue |
1 202
N/A
|
920
-23%
|
956
+4%
|
1 315
+38%
|
1 409
+7%
|
1 511
+7%
|
1 623
+7%
|
1 722
+6%
|
|
| Gross Profit | |||||||||
| Cost of Revenue |
(933)
|
(712)
|
(754)
|
(1 041)
|
(1 122)
|
(1 206)
|
(1 287)
|
(1 362)
|
|
| Gross Profit |
269
N/A
|
208
-23%
|
201
-3%
|
274
+36%
|
287
+5%
|
304
+6%
|
336
+10%
|
360
+7%
|
|
| Operating Income | |||||||||
| Operating Expenses |
(167)
|
(130)
|
(128)
|
(181)
|
(199)
|
(218)
|
(248)
|
(271)
|
|
| Selling, General & Administrative |
(57)
|
(41)
|
(36)
|
(53)
|
(65)
|
(69)
|
(77)
|
(80)
|
|
| Research & Development |
(121)
|
(96)
|
(99)
|
(134)
|
(134)
|
(150)
|
(170)
|
(187)
|
|
| Depreciation & Amortization |
(6)
|
0
|
0
|
0
|
(9)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
18
|
9
|
7
|
6
|
9
|
0
|
(1)
|
(4)
|
|
| Operating Income |
102
N/A
|
79
-23%
|
73
-7%
|
93
+27%
|
88
-6%
|
86
-2%
|
88
+2%
|
89
+1%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
8
|
8
|
16
|
19
|
13
|
15
|
12
|
10
|
|
| Non-Reccuring Items |
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
(0)
|
(0)
|
(0)
|
0
|
(1)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
110
N/A
|
87
-21%
|
89
+3%
|
112
+26%
|
101
-10%
|
101
0%
|
99
-2%
|
97
-2%
|
|
| Net Income | |||||||||
| Tax Provision |
3
|
6
|
2
|
2
|
0
|
0
|
1
|
(3)
|
|
| Income from Continuing Operations |
114
|
93
|
91
|
114
|
101
|
101
|
101
|
95
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Net Income (Common) |
114
N/A
|
93
-18%
|
91
-2%
|
114
+25%
|
101
-12%
|
101
+0%
|
101
0%
|
95
-6%
|
|
| EPS (Diluted) |
1.23
N/A
|
1.01
-18%
|
0.99
-2%
|
1.24
+25%
|
1.1
-11%
|
1.1
N/A
|
1.1
N/A
|
1.03
-6%
|
|